Constellation Pharmaceuticals Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$496.2M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Constellation Pharmaceuticals's estimated annual revenue is currently $28.3M per year.(i)
  • Constellation Pharmaceuticals received $100.0M in venture funding in April 2018.
  • Constellation Pharmaceuticals's estimated revenue per employee is $201,000
  • Constellation Pharmaceuticals's total funding is $496.2M.

Employee Data

  • Constellation Pharmaceuticals has 141 Employees.(i)
  • Constellation Pharmaceuticals grew their employee count by -14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M347-5%$634MN/A
#2
$50.9M253N/AN/AN/A
#3
$39.6M197-12%N/AN/A
#4
$11.6M2140%$506.4MN/A
#5
$4360M37257175%N/AN/A
#6
$16.3M81N/AN/AN/A
#7
$37.2M185N/AN/AN/A
#8
$3.2M16N/AN/AN/A
#9
$5.6M28-3%N/AN/A
#10
$888.2M44190%N/AN/A

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression. Our integrated epigenetics platform enables us to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. We are able to target a broad variety of epigenetic regulators using our platform and have generated development candidates acting against distinct classes of those regulators.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$496.2M

Total Funding

141

Number of Employees

$28.3M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Constellation Pharmaceuticals News

2021-06-02 - MORPHOSYS AG MorphoSys : to Acquire Constellation Pharmaceuticals

DGAP-News: MorphoSys AG / Key word(s): Mergers & Acquisitions MorphoSys to Acquire Constellation Pharmaceuticals 02.06.2021 / 13:24 The issuer is solely responsible for the content of this announcement. MorphoSys to Acquire Constellation Pharmaceuticals Accelerates Growth Strategy by Adding ...

2021-06-02 - MORPHOSYS AG MorphoSys : to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma

Ad hoc release according to article 17 para. 1 MAR Planegg/Munich, Germany and Cambridge, Mass., June 2, 2021 Ad hoc: MorphoSys to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma MorphoSys AG (FSE: MOR; NASDAQ: MOR) ("MorphoSys"), announ ...

2021-06-03 - CONSTELLATION PHARMACEUTICALS, INC. Constellation Pharmaceuticals : MorphoSys to Acquire Constellation Pharmaceuticals (Form 8-K)

MorphoSys to Acquire Constellation Pharmaceuticals Accelerates Growth Strategy by Adding Two Mid- to Late-Stage Product Candidates: Pelabresib (CPI-0610) and CPI-0209 Bolsters Position in Hematology-Oncology and Expands into Solid Tumors Best-in-Class Combined Discovery and Development Capab ...

09/03/2019 - Analysts Anticipate Constellation Pharmaceuticals Inc (NASDAQ:CNST) to Post -$0.81 EPS

Wall Street analysts expect Constellation Pharmaceuticals Inc (NASDAQ:CNST) to report earnings per share of ($0.81) for the current fiscal ...

09/08/2019 - Constellation Pharmaceuticals to Participate in Two Investor Conferences

CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (CNST), a clinical-stage biopharmaceutical ...

09/03/2019 - Constellation Pharmaceuticals, Inc. (:CNST) Buckles Under ...

We see here that Constellation Pharmaceuticals, Inc. (:CNST) is -2.10% away from the 20-Day Simple Moving Average. Their 50-Day Simple ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22M14228%$333.5M
#2
$25.5M1426%N/A
#3
$45.3M1422%N/A
#4
$22.6M1426%N/A
#5
$20M14314%$119.7M

Constellation Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2008-04-30$32.0MAThird Rock Ventures, The Column GroupArticle
2010-06-04$22.0MBSR OneArticle
2011-06-07$15.0MBMultipleArticle
2014-08-07$5.0MUndisclosedMultipleArticle
2015-12-11$55.0MUndisclosedArticle
2018-04-10$100.0MUndisclosedMultipleArticle